DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Scott Gottlieb - 25 Biden - 3 it's - 2 Eli Lilly's - 2 Eli Lilly - 2 Scott Gottlieb Dr - 2 Gottlieb - 1 OpenAI - 1
Top related locs:
New York City Covid Palo GLP NORD Novo Massachusetts Austria
Top related orgs:
FDA - 17 Former - 4 Medicare - 2 Administration - 2 UnitedHealth - 1 Change Healthcare - 1 Healthcare - 1 Medicaid Services - 1

Search resuls for: "Scott Gottlieb"


25 mentions found


☆ Dr. Gottlieb on Amgen's new weight loss drug: Expect to be on par with Wegovy & Mounjaro or better
  + stars: | 2024-05-06 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDr. Gottlieb on Amgen's new weight loss drug: Expect to be on par with Wegovy & Mounjaro or betterFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss Amgen's new injectable weight loss drugs, how it takes a different approach from other weight loss drugs like Wegovy and Mounjaro, state of the obesity drug market, and more.
Persons: Gottlieb, Scott Gottlieb Organizations: FDA
☆ Dr. Scott Gottlieb on the AI drug revolution, bird flu cattle outbreak latest
  + stars: | 2024-04-26 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDr. Scott Gottlieb on the AI drug revolution, bird flu cattle outbreak latestFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of Moderna's partnership with OpenAI to expand its employees access to AI chatbots, impact of the AI drug revolution, Dr. Gottlieb's venture into AI, latest developments on the bird flu cattle outbreak, and more.
Persons: Scott Gottlieb, OpenAI Organizations: FDA
☆ Some cancer drugs remain unproven 5 years after FDA's accelerated approval, study finds
  + stars: | 2024-04-09 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailSome cancer drugs remain unproven 5 years after FDA's accelerated approval, study findsFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss a new study showing some cancer drugs fast racked by the FDA's accelerated approval program remain unproven 5 years after the approvals, news of bird flu spreading in dairy cows, how worried the public should be, and more.
Persons: FDA's, Scott Gottlieb
☆ The technology behind Neuralink's implants has promise: Former FDA Commissioner Dr. Scott Gottlieb
  + stars: | 2024-03-27 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThe technology behind Neuralink's implants has promise: Former FDA Commissioner Dr. Scott GottliebFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the scrutiny over Neuralink's human trials, the technology behind the implants, approval of Merck's new treatment for a deadly lung condition, and more.
Persons: Scott Gottlieb
☆ UnitedHealth Group has paid more than $2 billion to providers following cyberattack
  + stars: | 2024-03-18 | by ( Ashley Capoot | In | ) www.cnbc.com   time to read: +3 min
UnitedHealth Group said Monday that it's paid out more than $2 billion to help health-care providers who have been affected by the cyberattack on subsidiary Change Healthcare. "We continue to make significant progress in restoring the services impacted by this cyberattack," UnitedHealth CEO Andrew Witty said in a press release. "We know this has been an enormous challenge for health care providers and we encourage any in need to contact us." It also introduced a temporary funding assistance program to help health-care providers experiencing cash flow trouble because of the attack. A survey published by the American Hospital Association on Friday found that 94% of hospitals have experienced financial disruptions from the Change Healthcare attack.
Persons: it's, Andrew, UnitedHealth, Rick Pollack, Biden, UnitedHealth hasn't, Scott Gottlieb Organizations: UnitedHealth, Change Healthcare, Healthcare, Medicare, Medicaid Services, American Hospital Association, Administration, U.S . Department of Health, Human Services, Office, Civil Rights, Palo Alto Networks, Google Locations: Palo
☆ Dr. Scott Gottlieb on UnitedHealth hack: Very pervasive across the entire health care system
  + stars: | 2024-03-15 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDr. Scott Gottlieb on UnitedHealth hack: Very pervasive across the entire health care systemFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the latest developments on the UnitedHealth hack, the impact on the U.S. health care system, and more.
Persons: Scott Gottlieb Organizations: FDA
☆ Fmr. FDA Commissioner weighs in on Medicare's involvement in GLP-1 prices
  + stars: | 2024-03-06 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFmr. FDA Commissioner weighs in on Medicare's involvement in GLP-1 pricesDr. Scott Gottlieb, Former FDA Commissioner, weighs in on the impact of GLP-1s on Medicare and the healthcare sector at large.
Persons: Scott Gottlieb Organizations: FDA, Medicare Locations: GLP
☆ Former FDA commissioner: GLP-1 drugs are a profound medical advance on par with statins
  + stars: | 2024-02-29 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFormer FDA commissioner: GLP-1 drugs are a profound medical advance on par with statinsDr. Scott Gottlieb, former FDA commissioner, joins 'Power Lunch' to discuss how big the GLP-1 drugs are likely to be, what could make the drugs hard for insurance not to pay for, and much more.
Persons: statins Dr, Scott Gottlieb Organizations: Former, statins, FDA
☆ 1 in 10 Americans are impacted by rare diseases 'it's a significant number', says NORD's Saltonstall
  + stars: | 2024-02-29 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email1 in 10 Americans are impacted by rare diseases 'it's a significant number', says NORD's SaltonstallPeter Saltonstall, NORD president and CEO, and Dr. Scott Gottlieb, former FDA commissioner, join 'Power Lunch' to discuss how you define what a rare disease is, how many people are affected by these rare diseases, and how costly the rare diseases are.
Persons: NORD's Saltonstall Peter Saltonstall, Scott Gottlieb Organizations: FDA Locations: NORD
☆ DOJ launches antitrust probe into UnitedHealth: Here's what to know
  + stars: | 2024-02-28 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDOJ launches antitrust probe into UnitedHealth: Here's what to knowFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the DOJ's antitrust probe into UnitedHealth, why he believes the moves has been long overdue, and more.
Persons: Scott Gottlieb Organizations: DOJ, FDA
☆ Former FDA Commissioner Dr. Scott Gottlieb on FTC's probe into drug shortages
  + stars: | 2024-02-16 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFormer FDA Commissioner Dr. Scott Gottlieb on FTC's probe into drug shortagesFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the FTC's probe into the generic drug supply chain, following a shortage of medicines over the past year that has forced hospitals to ration drugs.
Persons: Scott Gottlieb Organizations: Former, FDA
☆ The rise of 'Zynfluencers': What you need to know
  + stars: | 2024-02-08 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThe rise of 'Zynfluencers': What you need to knowFormer FDA Commissioner Dr. Scott Gottlieb joins 'The Exchange' to discuss the health concerns about Zyn, how the product has captured the market, and more.
Persons: Scott Gottlieb Organizations: FDA
☆ Ro, the $7 billion healthcare startup, has a high-stakes strategy to take off-brand Ozempic mainstream
  + stars: | 2024-02-07 | by ( ) www.businessinsider.com   time to read: +11 min
The $7 billion healthcare startup Ro, which has been prescribing brand-name weight-loss shots since January 2023, now offers compounded semaglutide to patients enrolled in its weight-management program. Nonetheless, Ro is the first prominent healthcare company to effectively endorse compounded semaglutide by prescribing it. A poor-quality compounded drug might simply be a dud and a waste of money. But while compounding pharmacies are subject to FDA and state regulations, states are the main regulators, and their oversight is patchy. Michael Siluk/UCG/Universal Images Group via Getty ImagesIt's hard to know if any given vial of compounded semaglutide is safe.
Persons: Wegovy's, Ro, drugmakers, Eli Lilly's, Eli Lilly's Mounjaro, Scott Gottlieb, Michael Siluk, That's, they've, Ozempic, Eli Lilly, Eric Kastango, they're, Kastango, aren't, Al Carter, Sarah Jones Simmer, Spencer Nadolsky, WeightWatchers, Tim Church, Wondr, it's, hasn't Organizations: Business, Novo Nordisk's Wegovy, US Food and Drug Administration, FDA, Novo Nordisk's Ozempic, Getty, Novo Nordisk, USP, National Association of, Pharmacy, Health Locations: Novo, Massachusetts, Austria, New York City
☆ Insurers likely to cover weight-loss drugs, if they show profound benefit: Dr. Scott Gottlieb
  + stars: | 2024-02-02 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailInsurers likely to cover weight-loss drugs, if they show profound benefit: Dr. Scott GottliebFormer FDA Commissioner Dr. Scott Gottlieb joins 'Power Lunch' to discuss the latest headlines in weight loss drugs.
Persons: Scott Gottlieb
☆ CVS's model will stabilize retail pharmacy margins, says Scott Gottlieb
  + stars: | 2023-12-05 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCVS's model will stabilize retail pharmacy margins, says Scott GottliebDr. Scott Gottlieb, former FDA commissioner, joins 'The Exchange' to discuss CVS Health's drug pricing, the role of AI in medicine, and more.
Persons: Scott Gottlieb Dr, Scott Gottlieb Organizations: FDA, CVS
☆ Trump’s avalanche of dishonesty: Fact-checking 102 of his false claims from this fall
  + stars: | 2023-12-01 | by ( Daniel Dale | ) edition.cnn.com   time to read: +111 min
Below is a fact check of 102 of Trump’s false claims from the 12 speeches. But contrary to Trump’s claim, it’s not true that people had been attempting for decades to create such an initiative. Trump’s aid to farmersIn speech after speech, Trump claimed that he had given US farmers $28 billion from China. Even if the poll result is off, it’s clear that Trump’s claim that “nobody wants them” is not true. He said he was an airline pilot.”Facts First: Trump made a false claim while mocking Biden for making false claims.
Persons: Donald Trump, –, Trump, Joe Biden, Biden, Ron DeSantis, Nikki Haley, “, ”, Mexico’s, ‘ Trump, Defense Department –, ” Theresa Cardinal Brown, CNN’s Priscilla Alvarez, ” Trump, I’ve, Todd Harrison, Harrison, It’s, Trump’s, ” Ben Cahill, Nobody, Jimmy Carter’s, Barack Obama, isn’t, El Salvador –, Obama, we’d, Obama’s, Webster, Covid, Wuhan ”, They’d, they’d, you’d, Scott Gottlieb, ” Gottlieb, Trump Trump, it’s, Abraham, Aaron David Miller, Miller, Dana El Kurd, Qasem Soleimani, they’ve, we’re, We’re, ’, Iran haven’t, ” Matt Smith, Biden’s, Smith, Ali Vaez, Kpler, Biden Trump, Iran “, Democrats ”, that’s, Jimmy Carter, Carter “, Carter, ‘, Hillary Clinton, Kari Lake, Bill Gates, Gates, ” Chris Wallace, Chris Wallace, Hunter Biden, “ Chris Wallace, ‘ He’s, ‘ ” Trump, Wallace, “ you’re, “ Biden, ‘ You’re, Wallace interjected, Rather, you’ve, ’ ” Pavel Molchanov, Raymond James &, ” Molchanov, Tim Woody, Woody, autoworkers, CNN’s Ella Nilsen, Joe Biden’s, Erin Mellon, Gavin Newsom, Mellon, ” Vonette Fontaine, Biden “, CNN’s Matt Egan, Egan, ” Biden, Europe Trump, United Kingdom “, Brent, Pavel Molchanov, Raymond James, Patrick De Haan, GasBuddy, De Haan, Matt Smith, Matt Egan, Afghanistan Trump, we’ve, Krista Wiegand, Wiegand, ” Netanyahu, Benjamin Netanyahu, Israel, Qasem, Bibi, Netanyahu, Soleimani, Asad, Mark Milley, Hezbollah Trump, Steven Cheung, John Kirby, Cheung, Kirby, Iran’s, ” Ali Vaez, Joseph Amon, Washington –, Faiq Zidan, Zidan’s, Zidan, Abu Mahdi al, China Trump, Ukraine Trump, Letitia James, James, Attorney Alvin Bragg, Matthew Colangelo, You’re, Bragg, Colangelo, Tanya Chutkan, I’m, Jack Smith, Bill Clinton, That’s, everybody’s, Letitia James –, Al Capone’s, Al Capone, Capone, Brad Schwartz, CNN couldn’t, Schwartz, Eliot Ness, MAGA, “ MAGA, …, White, CNN’s Fareed Zakaria, Inflation Trump, Bacon, Joe, PolitiFact, Trump . Howard Gleckman Organizations: Washington CNN —, CNN, Republican, Trump Trump, Republican Jewish Coalition, Department, ISIS, Trump’s, Democratic, Congress, Defense Department, former Defense Department, Center, US Customs, Trump, American Enterprise Institute, Air Force, Army, Navy, Marine Corps, Strategic Petroleum Reserve, Energy Security, Center for Strategic, International Studies, US, IHS, Islamic, The State Department, Customs Enforcement, Policy Institute, ICE, El Salvador, ”, Merriam, The New York Times, Food and Drug Administration, FDA, Abraham Accords, United Arab Emirates, West Bank, Hezbollah, State Department, Carnegie Endowment, International, Arab Center Washington DC, Islamic Revolutionary Guards Corps Quds Force, Obama, US International Trade Commission, Washington Post, U.S . International Trade Commission, New England lobstermen, England lobstermen, Americas, Crisis, government’s Energy, Administration, Washington Free Beacon, Energy Information Administration, Democrats, Biden, Electoral, Georgia, Michigan, Carter, Democrats can’t, Republicans, Alabama, Arizona, Fox News, ” Energy, Oceanic, Atmospheric Administration, NOAA, Wildlife, Alaska Industrial Development, Export Authority, Raymond James & Associates, Wilderness Society, Cox Automotive, Pew Research Center, New York Times, National Oceanic, California Gov, California, American Petroleum Institute, Union, West, Energy, American Automobile Association, AAA, GasBuddy, New Hampshire, Houston, Keystone XL, Obama administration’s State Department, –, Foreign, Military, DoD, Afghan, Defense, Policy, Taiwan News, “, University of Tennessee’s Center for National Security, Foreign Affairs, Israeli, NBC, Jerusalem Post, Yahoo, Pentagon, ” CNN, Joint Chiefs, Staff, Post, National Security, Group, US government’s Defense Intelligence Agency, Narcotics Bureau, Global Health, Drexel University Dornsife School of Public Health, Justice Department, Washington, Judicial, Popular Mobilization Forces, Customs and, Middle East, Customs, Protection, CBP, Border Protection, Kiel Institute, European Union, New York, New, ExxonMobil, Trump University, Trump Foundation, Manhattan, Attorney, federal Justice Department, Department of Justice, Washington DC, Presidential Records, Presidential, Mar, Biden White, MAGA Republicans, Inflation, Heritage Foundation, Trump ., Brookings Tax, Urban Institute Locations: New Hampshire, New York City, Saudi, Florida, al Qaeda, New York, Texas, Iowa, Mexico, “, U.S, Houston, Iraq, Israel, Tel Aviv, Jerusalem, Nord, Germany, Russian, Trump’s, Russia, Ukraine, Europe, Guatemala, Honduras, El Salvador, El, Washington, ”, ” In Texas, Covid, China, Wuhan, Italy, France, Abraham, Bahrain, Morocco, Sudan, Gaza, Lebanon, Syria, Iran, Yemen, Libya, Palestine, Afghanistan, Somalia, Pakistan, New England, England, Kpler, Malaysia, Oregon, Alabama, Maricopa County, Arizona, Arizona’s, Moscow, Alaska, East, South Carolina, California, “ California, West Virginia, Virginia, United Kingdom, West Texas, “ U.S, Los Angeles, Venezuela, Mississippi , Louisiana, Canada, United States, Paris, Taiwan, “ China, Iranian, that’s, –, Singapore, Iraqi, San Diego, Kiel, York, Manhattan, York’s, Chicago, Philadelphia, Georgia, Qaeda
☆ Former FDA commissioner: Expect more competition in Eli Lilly and Novo Nordisk's weight-loss drugs
  + stars: | 2023-11-09 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFormer FDA commissioner: Expect more competition in Eli Lilly and Novo Nordisk's weight-loss drugsFormer FDA commissioner Dr. Scott Gottlieb joins 'Power Lunch' to discuss Eli Lilly's highly anticipated weight-loss drug Zepbound, the demand and supply equation in the weight-loss drug space, and more.
Persons: Eli Lilly, Novo, Scott Gottlieb, Eli Lilly's, Zepbound Organizations: Former
☆ Former FDA commissioner Dr. Scott Gottlieb on the future of gene therapy
  + stars: | 2023-11-01 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFormer FDA commissioner Dr. Scott Gottlieb on the future of gene therapyFormer FDA commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the future of gene therapy, after Sarepta Therapeutics revealed new data for its Duchenne Muscular Dystrophy gene therapy fell short of expectations, the state of Covid-19, and more.
Persons: Scott Gottlieb Organizations: Former, Sarepta Therapeutics Locations: Covid
☆ Drugmakers test weigh-loss shots for kids as young as 6
  + stars: | 2023-10-20 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDrugmakers test weigh-loss shots for kids as young as 6Former FDA commissioner Dr. Scott Gottlieb joins 'Power Lunch' to discuss the latest weight loss headlines.
Persons: Scott Gottlieb Organizations: FDA
☆ Dr. Scott Gottlieb: The challenge with A.I. tools is getting it regulated by FDA as medical devices
  + stars: | 2023-09-25 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDr. Scott Gottlieb: The challenge with A.I. tools is getting it regulated by FDA as medical devicesFormer FDA commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the integration of A.I. into health care, how the technology can alter the industry, and more.
Persons: Scott Gottlieb Organizations: FDA
☆ FDA Advisory Committee: Ingredient in common decongestant ineffective
  + stars: | 2023-09-14 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailFDA Advisory Committee: Ingredient in common decongestant ineffectiveDr. Scott Gottlieb joins 'Power Lunch' to discuss cold medicine being found to be ineffective in decongestant and the latest push from the government for Americans to get vaccinated against Covid-19.
Persons: Scott Gottlieb Organizations: FDA, Covid Locations: decongestant
☆ Ozempic, Wegovy trials show positive results for Dementia, alcohol addiction
  + stars: | 2023-09-08 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailOzempic, Wegovy trials show positive results for Dementia, alcohol addictionFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the list of applications for new weight-loss drugs, how the weight-loss drugs can help neurocognitive conditions, and much more.
Persons: Scott Gottlieb
☆ Current Covid strain less pathogenic than delta variant, says Dr. Scott Gottlieb
  + stars: | 2023-09-05 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCurrent Covid strain less pathogenic than delta variant, says Dr. Scott GottliebFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the recent patch of Coronavirus diagnoses, whether the current batch of weight loss drugs is the right way to lose weight, and more.
Persons: Scott Gottlieb
☆ Medicare drug price negotiations will shrink the focus of R&D pursuits, says Dr. Scott Gottlieb
  + stars: | 2023-08-29 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMedicare drug price negotiations will shrink the focus of R&D pursuits, says Dr. Scott GottliebDr. Scott Gottlieb, a former FDA commissioner and also serves on the boards of Pfizer and Illumina, joins 'The Exchange' to discuss the inflation reduction act creating an avenue for medicare to directly negotiate prices with pharmaceutical companies, the unintended consequences of price regulation on drug development, and what ten prescription drugs are first to be considered.
Persons: Scott Gottlieb Dr, Scott Gottlieb Organizations: FDA, Pfizer, Illumina
☆ Dr. Scott Gottlieb on the Medicare drug cost battle as Pres. Biden targets drug prices
  + stars: | 2023-08-28 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDr. Scott Gottlieb on the Medicare drug cost battle as Pres. Biden targets drug pricesFormer FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the latest in Medicare's drug cost battle, as the Biden administration is expected to release a list of 10 drugs for which Medicare will negotiate prices, and more.
Persons: Scott Gottlieb, Pres, Biden Organizations: FDA
0 next >>
Total: 25